FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4536811000001109: Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17854101000001115 Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17854201000001110 Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Is a Clonidine hydrochloride 250micrograms m/r capsule false Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has active ingredient Clonidine hydrochloride true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Is a Catapres PL Perlongets true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has specific active ingredient Clonidine hydrochloride true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Is a Clonidine 250microgram modified-release capsules false Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Is a Clonidine 250microgram modified-release capsules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) 56 capsule Is pack of False Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier
Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) 56 capsule Has AMP True Catapres PL Perlongets 250microgram capsules (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start